India's transgender law shifts, creating healthcare access challenges and financial burdens

When transgender woman Kali Sidharth Medepalli began hormone replacement therapy in India, she did so under one set of rules. New government policy is changing that landscape. The Malay Mail Life reported on September 17, 2026, that revisions to India’s transgender law are creating uncertainty for patients and doctors.

The core of the issue lies in altered procedures for obtaining certificates that confirm a person's transgender identity. Previously, such certificates could be issued with a self-declaration. The new policy mandates a psychiatric assessment and approval from a district magistrate. This change shifts from a self-identification model towards a medical and bureaucratic gatekeeping system.

For individuals like Medepalli, who are already engaged in medical transition, the shift could mean disruption. The previous system allowed for a more direct path to legal recognition and access to gender-affirming care. The new requirements introduce additional steps and potential delays, which can carry significant costs. Each required visit to a psychiatrist or magistrate represents a fee, time away from work, and travel expenses. For those managing a monthly budget, these new hurdles could make continued treatment difficult to afford or even impossible.

Medical professionals also face new complexities. Doctors who previously provided care based on informed consent and a patient's self-identification may now need to navigate a more stringent legal framework. This could lead to a reduction in the number of doctors willing or able to provide gender-affirming care, particularly in regions where specialist resources are already limited. Uncertainty could also lead to inconsistent application of the law across different districts, creating varied access.

Some medical professionals question the medical necessity of psychiatric evaluation for identity confirmation, especially for individuals already living as their affirmed gender, according to the Malay Mail Life report. This raises questions about whether the new policy serves to protect patients or creates barriers. The increased bureaucratic load could deter both patients and providers, potentially pushing individuals towards unregulated or less safe options, which is a public health concern.

The implications for Thailand and the wider Asia-Pacific region are worth considering. Thailand plays a role in medical tourism for gender-affirming care, attracting individuals from across the globe, including India. If access to care within India becomes more difficult or expensive, more Indian citizens might seek care in Thailand. This would increase demand on Thai medical facilities but also potentially place a greater financial burden on individuals, who would incur costs for travel, accommodation, and the treatment itself, in addition to lost income during their stay. This kind of medical travel is not feasible for everyone, highlighting a disparity in access based on economic means.

While the stated intention behind the policy change may be to ensure proper medical and legal oversight, the practical effect on individuals’ monthly budgets and access to necessary healthcare is substantial. The decision to pursue gender-affirming care is already personal and often financially challenging. The new legal framework in India adds layers of complexity and cost, making it harder for many to maintain their chosen path. The outcome now depends on how consistently and compassionately the new regulations are applied, and how individuals and medical systems adapt to them.